Abacus Wealth Partners’s Eli Lilly LLY Stock Holding History

Abacus Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Sell	1,508 -1,193	-44%	-$1.22M	0.19%	35
2026 Q1	$2.48M	Sell	2,701 -7	-0.3%	-$7.1K	0.23%	37
2025 Q4	$2.91M	Buy	2,708 +2,305	+572%	+$2.2M	0.29%	29
2025 Q3	$307K	Hold	403	–	–	0.04%	74
2025 Q2	$314K	Sell	403 -34	-8%	-$26.4K	0.05%	78
2025 Q1	$361K	Buy	437 +6	+1%	+$4.99K	0.05%	59
2024 Q4	$333K	Sell	431 -184	-30%	-$152K	0.05%	57
2024 Q3	$545K	Buy	615 +65	+12%	+$58.4K	0.08%	48
2024 Q2	$498K	Buy	550 +31	+6%	+$24.8K	0.08%	47
2024 Q1	$404K	Buy	+519	New	+$369K	0.07%	54

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Abacus Wealth Partners's LLY Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Eli Lilly (LLY) stake by 44% in Q2 2026, selling an estimated $1.22M and leaving 1,508 shares worth $1.81M. The position accounts for 0.19% of the portfolio, ranked #35.

Abacus Wealth Partners first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.91M in Q4 2025. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Abacus Wealth Partners held 1,508 shares of Eli Lilly worth $1.81M as of Q2 2026.
Abacus Wealth Partners sold 1,193 Eli Lilly shares in Q2 2026, an estimated $1.22M.
Eli Lilly made up 0.19% of Abacus Wealth Partners's portfolio in Q2 2026, its #35 holding.
Abacus Wealth Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
Abacus Wealth Partners's Eli Lilly position peaked at $2.91M in Q4 2025.
1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.